339.97

0.81% -2.76

After Hours: 339.97

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $339.97, with a volume of 337.81K. It is down -0.81% in the last 24 hours and down -2.52% over the past month. West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$342.73

Open:

$339.76

24h Volume:

337.81K

Relative Volume:

0.50

Market Cap:

$23.93B

Revenue:

$3.22B

Net Income/Loss:

$542.70M

P/E Ratio:

45.45

EPS:

7.4805

Net Cash Flow:

$458.00M

1W Performance:

+0.74%

1M Performance:

-2.52%

6M Performance:

+36.62%

1Y Performance:

+37.34%

1-Day Range:

$339.76

$342.67

1-Week Range:

$335.51

$346.00

52-Week Range:

$223.83

$386.00

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1074)

Industry

Medical Instruments & Supplies (56)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,800

Twitter

@WestPharma

Next Earnings Date

2026-10-22

Latest SEC Filings

WST's Discussions on Twitter

Compare WST vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	339.97	24.90B	3.22B	542.70M	458.00M	7.4805
ISRG Intuitive Surgical Inc	366.70	132.30B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	184.74	51.11B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	70.50	35.25B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	228.35	32.95B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	36.59	28.58B	29.14B	1.07B	1.05B	1.1956

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Initiated	Morgan Stanley	Equal-Weight
Sep-15-25	Initiated	Rothschild & Co Redburn	Buy
Jun-24-25	Initiated	Barclays	Equal Weight
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

01:10 AM

West Pharmaceutical stock gains after strong Q2 figures - AD HOC NEWS

01:10 AM

12:20 PM

Philips Expands Women's Health Ultrasound Portfolio With New Transducer - Zacks Investment Research

12:20 PM

11:12 AM

Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView

11:12 AM

09:42 AM

Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance

09:42 AM

05:14 AM

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews

05:14 AM

Sep 05, 2026

Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - IndexBox

Sep 05, 2026

Sep 04, 2026

West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance

Sep 04, 2026

Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView

Sep 04, 2026

West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - AD HOC NEWS

Sep 04, 2026

Sep 02, 2026

West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media

Sep 02, 2026

West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Sep 02, 2026

West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - AD HOC NEWS

Sep 02, 2026

Sep 01, 2026

West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS

Sep 01, 2026

Aug 31, 2026

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 31, 2026

West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS

Aug 31, 2026

West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews

Aug 31, 2026

Aug 28, 2026

Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com

Aug 28, 2026

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch

Aug 28, 2026

Aug 27, 2026

West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch

Aug 27, 2026